ArticleNaunyn-Schmiedeberg's archives of pharmacology2016

Febuxostat protects rats against lipopolysaccharide-induced lung inflammation in a dose-dependent manner.

Alaa N A Fahmi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.